Share Capital (Tables)

12 Months Ended

Dec. 31, 2021

Stockholders' Equity Note [Abstract]

Summary of the effect of share-based compensation on the statements of operations

(2)The expenses that were recognized in the consolidated statements of operations for services received from employees and service providers are as follows:

	Year ended		Year ended
	December 31,		December 31,
	2021		2020
	USD thousands		USD thousands
Research and development		137		84
General and administrative		1,882		46

Total share-based compensation expenses		2,019		130

Summary of number and weighted average exercise prices of option

(3)The number and weighted average exercise price of options are as follows:

	Weighted average exercise price		Number of options			Weighted average remaining contractual life (in years)		Weighted average exercise price		Number of options			Weighted average remaining contractual life (in years)
	2021		2021			2021		2020		2020			2020
Outstanding at January 1		0.07		10,455,580			7.8		0.07		8,072,704			8.09
Acquired in Merger				609,535
Exercise		0.08		(134,220	)		-		-		-			-
Forfeited		1.25		(1,712,275	)		-		0.07		(10,804	)		-
Granted		0.62		17,784,640			9.79		0.08		2,393,680			9.77

Outstanding at December 31		0.38		27,003,260			8.12		0.07		10,455,580			7.8

Summary of assumptions used to calculate the fair value of the options

The fair value of the options is measured at the grant date using the Black-Scholes Option pricing model and the assumptions used to calculate the fair value of the options are as follows:

	2021 grants
Weighted average share price (in U.S. dollar)^(a)		9.44-27.26
Exercise price (in U.S. dollar)		9.44-27.26
Expected life of options (in years)^(b)		5.73-6.28
Expected volatility^(c)		65.93%-70.88%
Risk-free interest rate^(d)		1.36%-1.64%
Dividend yield		0%